Patellofemoral disorders.
Conditions
Interventions
Intervention 1: Intervention group:The same as control group plus gluteus medius and quadratus lumborum dry needling for 4 sessions , are given over a period of four weeks one session per weeks.The ne
quadriceps setting in 10 degree terminal knee extension(3set 10 repetition),second week:sideling straight leg raises and hip abductors and external rotator strengthening exercise (Clamshells)(3 set, 1
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 18 to 45 years old with unilateral or bilateral patellofemoral pain syndrome; anterior or retropatellar knee pain during at least 2 following activities: prolonged sitting, ascending or descending stair,squatting, kneeling, jumping and running; pain on palpation of medial and lateral patellar facets and positive patellar grind test; an insidious onset of symptoms not related to trauma for the last 3 months; Kujula scores less than 85 out of 100; numeric rate scale scores ranging 3 to 10 during last week. having trigger point in the gluteus medius muscle in the affected side and quadratos lumbar muscle in the non-affected side
Exclusion criteria
Exclusion criteria: Other knee joint pathologies such as meniscus and ligament injuries, osteoarthritis and tendon impairments; patellar subluxations or dislocations; Sinding-Larsen disease;Osgood–Schlatter disease; pelica syndrome;ankle and knee injury; hip joint pathologies such as ligament injuries, osteoarthritis and tendon impairments; subluxations or dislocations and hip injury; referral pain from other joints including lumbar spine, hip and sacroiliac joints and spinal fractures; LBP without source of myofascial; any pain during sitting such as Coccydynia; previous knee surgery; Structural and biomechanical problems such as: Varus and Valgus knee; overweight 32< BMI Prohibition the use of dry needles such as:metabolic diseases such as diabetes, rheumatic diseases and neuromuscular diseases; pregnancy; Respiratory and peripheral vascular disease, cancer and any malignancy; Immune deficiency; Menstruation; needle phobia; Hemorrhagic diseases and the use of anticoagulant drugs; liver and kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain threshold. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: algometry.;Pain intensity. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Numeric Rate Scale (NRS).;Functional steping. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Step down test.;Function. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: kujula questionnaire.;Balance. Timepoint: first and 8th sessions and 2 weeks after the intervention. Method of measurement: Y-Balance Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh zarei
Shiraz University of Medical Sciences
Outcome results
None listed